Cholinesterase inhibitor treatment slows decline in function and multiple cognitive domains in Alzheimer's disease: A 1-year, prospective study in the Sunnybrook Dementia Cohort

被引：0
|
作者：
Behl, P
Black, SE
Streiner, DL
Lanctot, K
机构：
来源：
NEUROLOGY | 2005年 / 64卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A145 / A145
页数：1
相关论文
共 50 条
  • [1] The effect of cholinesterase inhibitors on decline in multiple functional domains in Alzheimer's disease: a two-year observational study in the Sunnybrook dementia cohort
    Behl, Pearl
    Lanctot, Krista L.
    Streiner, David L.
    Black, Sandra E.
    INTERNATIONAL PSYCHOGERIATRICS, 2008, 20 (06) : 1141 - 1159
  • [2] Cholinesterase inhibitors slow decline in function in Alzheimer's Disease (AD): A 2-year observational study in the Sunnybrook dementia cohort
    Behl, P
    Lanctot, K
    Streiner, D
    Black, S
    NEUROLOGY, 2006, 66 (05) : A121 - A121
  • [3] Cholinesterase inhibitors and Alzheimer's disease: A two-year study in the Sunnybrook dementia cohort
    Behl, Pearl
    Lanctot, Krista L.
    Streiner, David L.
    Black, Sandra E.
    ANNALS OF NEUROLOGY, 2006, 60 : S3 - S3
  • [4] Treatment effects in multiple cognitive domains in Alzheimer’s disease: a two-year cohort study
    Pearl Behl
    Jodi D Edwards
    Alexander Kiss
    Krista L Lanctot
    David L Streiner
    Sandra E Black
    Donald T Stuss
    Alzheimer's Research & Therapy, 6
  • [5] Treatment effects in multiple cognitive domains in Alzheimer's disease: a two-year cohort study
    Behl, Pearl
    Edwards, Jodi D.
    Kiss, Alexander
    Lanctot, Krista L.
    Streiner, David L.
    Black, Sandra E.
    Stuss, Donald T.
    ALZHEIMERS RESEARCH & THERAPY, 2014, 6 (04):
  • [6] Cystatin C predicts cognitive decline in multiple system atrophy: A 1-year prospective cohort study
    Zhang, Lingyu
    Li, Ruicen
    Hou, Yanbing
    Cao, Bei
    Wei, Qianqian
    Ou, Ruwei
    Liu, Kuncheng
    Lin, Junyu
    Yang, Tianmi
    Xiao, Yi
    Huang, Wenxia
    Shang, Huifang
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [7] Association of multiple metabolic and cardiovascular markers with the risk of cognitive decline and mortality in adults with Alzheimer's disease and AD-related dementia or cognitive decline: a prospective cohort study
    Liu, Longjian
    Gracely, Edward J.
    Zhao, Xiaopeng
    Gliebus, Gediminas P.
    May, Nathalie S.
    Volpe, Stella L.
    Shi, Jingyi
    DiMaria-Ghalili, Rose Ann
    Eisen, Howard J.
    FRONTIERS IN AGING NEUROSCIENCE, 2024, 16
  • [8] Comparison of cognitive decline between dementia with Lewy bodies and Alzheimer's disease: a cohort study
    Walker, Zuzana
    McKeith, Ian
    Rodda, Joanne
    Qassem, Tarik
    Tatsch, Klaus
    Booij, Jan
    Darcourt, Jacques
    O'Brien, John
    BMJ OPEN, 2012, 2 (01):
  • [9] Predictive Factors for Swallowing Function Decline in Older Adults With Alzheimer's Disease: A 1-Year Longitudinal Study
    Shirobe, Maki
    Edahiro, Ayako
    Motokawa, Keiko
    Morishita, Shiho
    Ohara, Yuki
    Watanabe, Yutaka
    Iwasaki, Masanori
    Hirano, Hirohiko
    JOURNAL OF ORAL REHABILITATION, 2025, 52 (03) : 375 - 383
  • [10] Factors associated with cognitive function in patient with Alzheimer's disease with newly prescribed acetylcholinesterase inhibitors: A 1-year retrospective cohort study
    Ching, Pao-Yuan
    Chang, Cheng-Ho
    Pan, Chih-Chuan
    Chiang, Yung-Chih
    Kuo, Hsin-ya
    Hsu, Tien-Wei
    Chu, Che-Sheng
    AGING MEDICINE, 2024, 7 (03) : 312 - 319
12345